[Costs of schizophrenia - what we know (not)?]
- PMID: 11533903
- DOI: 10.1055/s-2001-15383
[Costs of schizophrenia - what we know (not)?]
Abstract
Schizophrenia is regarded as one of the most expensive mental illnesses because of its specific symptoms and characteristics. The care of schizophrenic patients consumed approx. 2 % of the total German health care expenditures in 1994, according to the scarce data provided by routine German health reporting. Despite this enormous impact, health-economical research in schizophrenia in Germany is widely neglected. While few empirical studies on direct cost of care for schizophrenic patients suggest that adequate comprehensive community care in Germany during the mid-nineties was about DM 27 000 to DM 28 000 per patient and year, there is a serious lackage of cost-effectiveness-studies, relating cost of care to outcome. Thus, the most basic data for any health care planning in schizophrenia is missing. This paper reviews the studies on cost of schizophrenia in Germany. It identifies the most serious knowledge gaps and describes the obstacles for an adequate research in this field.
Similar articles
-
[Direct health-related costs of severely mentally ill patients and their informal carers in community care].Neuropsychiatr. 2010;24(1):42-55. Neuropsychiatr. 2010. PMID: 20146919 German.
-
[The costs of schizophrenia].Fortschr Neurol Psychiatr. 1998 Nov;66(11):496-504. doi: 10.1055/s-2007-995290. Fortschr Neurol Psychiatr. 1998. PMID: 9850827 Review. German.
-
Making music out of noise--the cost function approach to evaluation.Br J Psychiatry Suppl. 1998;(36):7-11. Br J Psychiatry Suppl. 1998. PMID: 9829005 Review. No abstract available.
-
A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.J Ment Health Policy Econ. 2002 Mar;5(1):21-31. J Ment Health Policy Econ. 2002. PMID: 12529567
-
A comparison of effectiveness and cost between two models of care for individuals with schizophrenia living in Taiwan.Arch Psychiatr Nurs. 2001 Dec;15(6):272-8. doi: 10.1053/apnu.2001.28688. Arch Psychiatr Nurs. 2001. PMID: 11735078
Cited by
-
Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany.Pharmacoeconomics. 2005;23 Suppl 1:49-61. doi: 10.2165/00019053-200523001-00005. Pharmacoeconomics. 2005. PMID: 16416761
-
Overview and emerging trends.Indian J Psychiatry. 2005 Oct;47(4):205-10. doi: 10.4103/0019-5545.43052. Indian J Psychiatry. 2005. PMID: 20711306 Free PMC article. No abstract available.
-
The costs of schizophrenia and predictors of hospitalisation from the statutory health insurance perspective.Health Econ Rev. 2012 May 4;2(1):9. doi: 10.1186/2191-1991-2-9. Health Econ Rev. 2012. PMID: 22828440 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical